The Academy posted a news article last month about an FDA effort to solicit patient feedback specifically in the area of “treatments for moderate to severe hearing loss (implanted vs. other treatment options).”  To that end, the Academy’s Government Relations Committee authored the Patient Survey so that practitioners could print the document and provide it to their patients. The survey document includes specific instructions so that patients can complete the survey and then mail their responses directly to the FDA.

The FDA is hoping to glean from this feedback whether patients prefer certain outcomes or choices over others in terms of their health. In addition, the FDA wants to understand how patients view the risks and benefits of a technology or treatment differently from how the risk and benefits are viewed by health-care professionals and caregivers and whether differences in patient perspectives are not well understood due to a variety of factors.

Patient feedback should be postmarked on or before July 2, 2019.

Download the Patient Survey

Share this

Recent Posts

“Huh?” Is More Than an Interrogatory Palindrome!

Volunteer Spotlight: Riley DeBacker, AuD, PhD

Biden-Harris Administration Releases Playbook to Address Social Determinants of Health (SDOH)

Related Posts

Biden-Harris Administration Releases Playbook to Address Social Determinants of Health (SDOH)

A growing body of evidence demonstrates the connection between health outcomes to income, education, nutrition, housing, environmental exposures, and other social circumstances.  Similarly, studies have shown that interventions addressing SDOH can improve health outcomes and reduce health care costs. In response, the Biden-Harris Administration has released a playbook outlining new or strengthened initiatives that agencies…

Read More

Free Hearing Aids from Cochlear Implant Manufacturer May Violate Fraud and Abuse Laws

The U.S. Department of Health and Human Services Office of Inspector General (OIG) posted on October 25, 2023 Advisory Opinion No. 23-08, in which OIG rejected a proposed arrangement from a cochlear implant device manufacturer (the requestor) that would provide a free hearing aid to certain qualified patients who received a cochlear implant. OIG concluded the…

Read More

Representatives Bilirakis and Cartwright Introduce the Medicare Audiology Access Improvement Act of 2023 (H.R. 6445) 

On November 17, 2023, Representative Gus Bilirakis (R-FL) and Matt Cartwright (D-PA) introduced the Medicare Audiology Access improvement Act (H.R. 6445). This legislation is also co-sponsored by Representatives Johnson (R-OH), Shakowsky (D-IL), Mace (R-SC), Blunt Rochester (D-DE), Fitzpatrick (R-PA), Trone (D-MD), Webster (R-FL), Cohen (D-TN), LaMalfa (R-CA), Grijalva (D-AZ), Foster (D-IL) and Pocan (D-WI). Senators Elizabeth…

Read More